Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
September 13, 2023 16:13 ET
|
Scinai Immunotherapeutics Ltd.
Scinai’s NanoAbs downregulated key molecular markers overexpressed in plaque psoriasis Stratum corneum regained normal appearance in laboratory 3D skin model Results from ex-vivo study...
Enlitic’s ENDEX™ Addresses Implications and Challenges of Poor Medical Imaging Data at the Enterprise Level
August 24, 2023 10:00 ET
|
Enlitic
FORT COLLINS, Colo., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Healthcare organizations across the world are working with poor data. In fact, while high-quality data is a top strategic priority for...
Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
August 09, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication...
H1 Relaunches Faculty Opinions as H1 Connect, the Online Community Where HCPs and Researchers Access the Latest Breakthroughs in Medicine and Life Sciences Research
July 11, 2023 09:00 ET
|
H1
NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- H1, the leading source of truth for global HCP, clinical, scientific, and research information, today announced the launch of H1 Connect, formerly Faculty...
Datacubed Health Announces Collaboration with Special Forces Combat Veterans to Conduct Revolutionary Post-Traumatic Stress Study
June 14, 2023 07:00 ET
|
Datacubed Health
New York, New York, June 14, 2023 (GLOBE NEWSWIRE) -- Datacubed Health, a leading provider of innovative technology solutions for clinical research, is proud to announce its partnership with...
Landmark Study Investigating Novel Alzheimer’s Biomarkers Advances to Data Analysis Stage
June 14, 2023 06:00 ET
|
Global Alzheimer's Platform Foundation
WASHINGTON, DC, June 14, 2023 (GLOBE NEWSWIRE) -- Up to 50 percent of people in the U.S. with Alzheimer’s receive an imprecise or inaccurate diagnosis of their cognitive condition. The tools...
CDC Launches Fentanyl Dashboard Utilizing Data from the Toxicology Investigators Consortium (ToxIC) to Monitor Nonfatal Overdose Trends
June 09, 2023 12:54 ET
|
American College of Medical Toxicology
Phoenix, AZ, June 09, 2023 (GLOBE NEWSWIRE) -- Fentanyl, a powerful synthetic opioid, has emerged as a significant public health concern across the United States, contributing to a surge in...
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
June 08, 2023 09:00 ET
|
ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
May 25, 2023 09:00 ET
|
ResMed Inc.
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSAGermany’s Michael Arzt presented...
Axis Research & Technologies Announces Integration of OMNIMED™ SmartOR™
May 11, 2023 08:30 ET
|
Axis Research & Technologies
IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Axis Research & Technologies, a premier bioskills training and cadaver lab supporting medical device research and testing, announced the...